Roche, FDA confirm link of Tamiflu to severe psychiatric problems
Emergency Management Alert, March 25, 2008
Roche Laboratories Inc. and the Federal Drug Administration have confirmed the relationship between neuropsychiatric events associated with the use of Tamiflu in patients with influenza.
The symptoms, which include delirium and abnormal behavior leading to injury, have resulted in fatal outcomes. Many of these events were among pediatric patients and often had an abrupt onset and rapid resolution.
To read more, click here.
Comments
0 comments on “Roche, FDA confirm link of Tamiflu to severe psychiatric problems ”
Related Products
-
Hospital Safety Center
Improve compliance with hospital safety standards from The Joint Commission, OSHA, and other regulators with this...
-
Healthcare Life Safety Compliance
Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.
-
Hospital Safety Connection
Stay on top of hospital safety requirements and best practices with our free, fast-paced weekly update.
-
Administering Your OSHA Program
This course will help an employee new to the role of OSHA safety officer. It gives an overview of OSHA requirements and...
-
Medical OSHA Manual Combo
Get into compliance with Quality America's OSHA Safety Program Manual and stay in compliance with OSHA Watch Newsletter...
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- Q&A: Coding for dry skin due to cold weather
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Catch up on what's new with injections and infusions
- Privacy, security concerns high in HIEs
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- Q&A: Coding for sepsis when other conditions are present
- Are your workforce members texting PHI?
- HIPAA Q&A: TPO disclosures to a business associate
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- First board certification for hospitalists announced -- with caution
- Searched